Synthesis and biological activity of novel barbituric and thiobarbituric acid derivatives against non-alcoholic fatty liver disease
- 30 June 2011
- journal article
- Published by Elsevier BV in European Journal of Medicinal Chemistry
- Vol. 46 (6), 2003-2010
- https://doi.org/10.1016/j.ejmech.2011.02.033
Abstract
No abstract availableKeywords
Funding Information
- National Key Programs of China (2009ZX09102-045, 2009ZX09501-015)
This publication has 26 references indexed in Scilit:
- New PPARγ ligands based on barbituric acid: Virtual screening, synthesis and receptor binding studiesBioorganic & Medicinal Chemistry Letters, 2008
- The effect of thiazolidinediones on adiponectin serum level: a meta‐analysisDiabetes, Obesity and Metabolism, 2007
- Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver diseaseActa Endocrinologica, 2006
- Furan-2-ylmethylene Thiazolidinediones as Novel, Potent, and Selective Inhibitors of Phosphoinositide 3-Kinase γJournal of Medicinal Chemistry, 2006
- Treatment of non-alcoholic fatty liver diseaseHeart, 2006
- Non-alcoholic fatty liver disease: current concepts and management strategiesClinical Medicine, 2006
- Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazoneJournal of Hepatology, 2003
- Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndromeJournal of Hepatology, 2003
- NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndromeJournal of Hepatology, 2002
- Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severityGastroenterology, 1999